Literature DB >> 2355025

The effect of local extent of the tumor on prognosis in osteosarcoma.

S S Spanier1, J J Shuster, R A Vander Griend.   

Abstract

The effect of local extent of the tumor on disease-free survival was studied in fifty-one patients who had an osteosarcoma, all of whom were treated according to the same protocol. Disease-free survival was defined as the interval between entry into the protocol and local recurrence, metastasis, or death (whichever occurred first). All patients had a Stage-IIB intramedullary osteosarcoma--that is, a high-grade malignant tumor (Stage II) with cortical penetration (B). The tumors were subdivided on the basis of the amount of local extension: E1--the tumor touches but does not elevate or penetrate the periosteum; E2--the tumor elevates but does not penetrate the periosteum; E3--the tumor penetrates into, but not through, the periosteum; E4--there is minimum extraperiosteal extension without invasion of another structure, such as a muscle, tendon, or ligament; E5--the tumor invades one additional structure (a muscle, ligament, or tendon); and E6--the tumor invades two or more structures adjacent to the bone. When the tumor had invaded two or more adjacent structures (E6), the instantaneous risk of failure was estimated to be 5.9 times greater than when the tumor had a lesser extent (E1 through E5). The relative prognostic importance of the amount of local extension, the size of the tumor, and the sex and age of the patient was compared with forward step-wise Cox multivariate analysis. Only the amount of local extension had a significant effect on disease-free survival. The estimated cumulative probabilities of disease-free survival at five years, according to the Kaplan-Meier method, were 49.1 +/- 8.5 per cent for patients who had a Stage-IIB tumor, 79.8 +/- 9.3 per cent for those who had a Stage-IIB but not E6 tumor, and 17.6 +/- 11.3 per cent for those who had a Stage-IIB E6 tumor. These data suggest that, with respect to prognosis, there are two distinct subgroups of Stage-IIB osteosarcomas that can be objectively defined by the amount of local extension.

Entities:  

Mesh:

Year:  1990        PMID: 2355025

Source DB:  PubMed          Journal:  J Bone Joint Surg Am        ISSN: 0021-9355            Impact factor:   5.284


  11 in total

1.  Local growth and the prognosis of osteosarcoma.

Authors:  P Wuisman; W F Enneking; A Roesner
Journal:  Int Orthop       Date:  1992       Impact factor: 3.075

2.  Risk factors for metastatic disease at presentation with osteosarcoma: an analysis of the SEER database.

Authors:  Benjamin J Miller; Peter Cram; Charles F Lynch; Joseph A Buckwalter
Journal:  J Bone Joint Surg Am       Date:  2013-07-03       Impact factor: 5.284

3.  Age as a prognostic factor for patients with osteosarcoma: an analysis of 438 patients.

Authors:  Matthew T Harting; Kevin P Lally; Richard J Andrassy; Ara A Vaporciyan; Charles S Cox; Andrea Hayes-Jordan; Martin L Blakely
Journal:  J Cancer Res Clin Oncol       Date:  2009-09-27       Impact factor: 4.553

4.  Telangiectatic osteosarcoma: a review of 87 cases.

Authors:  Andrea Angelini; Andreas F Mavrogenis; Giulia Trovarelli; Stefano Ferrari; Piero Picci; Pietro Ruggieri
Journal:  J Cancer Res Clin Oncol       Date:  2016-07-28       Impact factor: 4.553

Review 5.  Treatment recommendations for osteosarcoma and adult soft tissue sarcomas.

Authors:  P Picci; S Ferrari; G Bacci; F Gherlinzoni
Journal:  Drugs       Date:  1994-01       Impact factor: 9.546

6.  Poster presentations.

Authors: 
Journal:  Sarcoma       Date:  2001

7.  A new relative tumor sizing method in epi-metaphyseal osteosarcoma.

Authors:  Seung Hyun Kim; Kyoo-Ho Shin; Eun Hae Park; Yong Jin Cho; Byoung-Kyu Park; Jin-Suck Suh; Woo-Ick Yang
Journal:  BMC Cancer       Date:  2015-04-15       Impact factor: 4.430

8.  Prognostic factors in the survival of patients diagnosed with primary non-metastatic osteosarcoma with a poor response to neoadjuvant chemotherapy.

Authors:  Rosalvo Zósimo Bispo Júnior; Olavo Pires de Camargo
Journal:  Clinics (Sao Paulo)       Date:  2009       Impact factor: 2.365

9.  Comparison of the outcome of conventional osteosarcoma at two specialist international orthopaedic oncology centres.

Authors:  Samuel Ford; Adnan Saithna; Robert J Grimer; Piero Picci
Journal:  Sarcoma       Date:  2004

10.  High tumor volume and local recurrence following surgery in osteosarcoma: A retrospective study.

Authors:  Rishi Ram Poudel; Venkatesan Sampath Kumar; Sameer Bakhshi; Shivanand Gamanagatti; Shishir Rastogi; Shah Alam Khan
Journal:  Indian J Orthop       Date:  2014-05       Impact factor: 1.251

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.